Ces Urol 2020, 24(1):69-73 | DOI: 10.48095/cccu2020008
Case report of a gigantic recurrent angiomyolipoma in a horseshoe kidney
- Oddělení urologické onkologie, Masarykův onkologický ústav, Brno
We present a case report of gigantic recurrent angiomyolipoma of the horseshoe kidney in a young patient with suspected tuberous sclerosis syndrome. The condition was solved by repeated cytoreductive surgery in combination of systemic treatment with mTOR inhibitors.
Keywords: Angiomyolipoma, tuberous sclerosis, horseshoe kidney, mTOR inhibitor.………
Received: January 30, 2020; Revised: February 13, 2020; Accepted: February 13, 2020; Prepublished online: February 16, 2020; Published: March 19, 2020
References
- Flum AS, Hamoui N, Said MA, et al. Update on the Diagnosis and Management of Renal Angiomyolipoma. J Urol 2016; 195: 834-846.
Go to original source... 
Go to PubMed... - Ürge T, Pitra T, Chudáček Z, et al. Nové trendy v léčbě renálního angiomyolipomu. Ces Urol 2015; 19(2): 106-117.
- Fernández‑Pello S, Hora M, Kuusk T, et al. Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology renal cell carcinoma guidelines panel. Eur Urol Oncol 2019 Jun 3. pii: S2588-9311(19)30054-9.
- Paldus V, Šámal V, Mečl J, et al. Wunderlichův syndrom - soubor pacientů s netraumatickým spontánním krvácením do retroperitonea. Ces Urol 2019; 23: 230-236.
- Hušek P, Košina J, Pacovský J, et al. Roboticky asistovaná resekce objemného angiomyolipomu levé ledviny. Ces Urol 2018; 22: 234-237.
- Samuels JA. Treatment of renal angiomyolipoma and other hamartomas in patients with tuberous sclerosis complex. Clin J Am Soc Nephrol 2017; 12: 1196-1202. Go to original source... Go to PubMed...
- Bhatt JR, Richard PO, Kim NS, et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4 cm can be offered active surveillance as an initial management strategy. Eur Urol 2016; 70: 85-90. Go to original source... Go to PubMed...
- McCormack FX, Inoue Y, Moss J, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 2011; 364: 1595-1606. Go to original source... Go to PubMed...
- Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus long‑term use in patients with tuberous sclerosis complex: four‑year update of the EXIST-2 study. PLoS One 2017; 12: e0180939. Go to original source...
- Toriu N, Mizuno H, Sawa N, et al. Everolimus reduces the size of tuberous sclerosis complex‑related huge renal angiomyolipomas exceeding 20 cm in the longest diameter. Case Rep Oncol 2018; 11: 258-267. Go to original source... Go to PubMed...